- Home
- MGIC vs ORIC Comparison
MGIC vs ORIC Comparison
Compare MGIC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- ORIC
- Stock Information
- Founded
- MGIC 1983
- ORIC 2014
- Country
- MGIC Israel
- ORIC United States
- Employees
- MGIC N/A
- ORIC N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- ORIC Health Care
- Exchange
- MGIC Nasdaq
- ORIC Nasdaq
- Market Cap
- MGIC 1.0B
- ORIC 974.1M
- IPO Year
- MGIC 1991
- ORIC 2020
- Fundamental
- Price
- MGIC $19.93
- ORIC $10.71
- Analyst Decision
- MGIC Buy
- ORIC Strong Buy
- Analyst Count
- MGIC 2
- ORIC 10
- Target Price
- MGIC $18.00
- ORIC $17.33
- AVG Volume (30 Days)
- MGIC 41.3K
- ORIC 886.3K
- Earning Date
- MGIC 08-13-2025
- ORIC 11-11-2025
- Dividend Yield
- MGIC 2.83%
- ORIC N/A
- EPS Growth
- MGIC 16.93
- ORIC N/A
- EPS
- MGIC 0.78
- ORIC N/A
- Revenue
- MGIC $584,528,000.00
- ORIC N/A
- Revenue This Year
- MGIC $11.11
- ORIC N/A
- Revenue Next Year
- MGIC $6.83
- ORIC N/A
- P/E Ratio
- MGIC $26.09
- ORIC N/A
- Revenue Growth
- MGIC 11.98
- ORIC N/A
- 52 Week Low
- MGIC $10.42
- ORIC $3.90
- 52 Week High
- MGIC $22.00
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MGIC 47.81
- ORIC 55.85
- Support Level
- MGIC $18.72
- ORIC $10.36
- Resistance Level
- MGIC $20.80
- ORIC $11.20
- Average True Range (ATR)
- MGIC 0.50
- ORIC 0.49
- MACD
- MGIC 0.02
- ORIC 0.06
- Stochastic Oscillator
- MGIC 55.25
- ORIC 67.35
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.